Human Papillomavirus Genotype Specificity of Hybrid Capture 2 (original) (raw)

Related papers

Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples

Ariana Quenaya

View PDFchevron_right

Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail

Katja Seme

Journal of clinical Virology, 2002

View PDFchevron_right

Prospective Evaluation of the Hybrid Capture 2 and AMPLICOR Human Papillomavirus (HPV) Tests for Detection of 13 High-Risk HPV Genotypes in Atypical Squamous Cells of Uncertain Significance

Hacène Khiri, D. Thibaud, Guillaume Pénaranda

Journal of Clinical Microbiology, 2007

View PDFchevron_right

Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results

Michael Quinn

Journal of Clinical Microbiology, 2007

View PDFchevron_right

HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice

Massimo Origoni

Ecancermedicalscience, 2012

View PDFchevron_right

Efficiency of the Hybrid Capture 2 HPV DNA Test in Cervical Cancer Screening

Vincent Molinié

American Journal of Clinical Pathology, 2003

View PDFchevron_right

Efficiency of the Hybrid Capture 2 HPV DNA Test in Cervical Cancer Screening: A Study by the French Society of Clinical Cytology

Catherine Le Galès

American Journal of Clinical Pathology, 2003

View PDFchevron_right

The Abbott RealTime High Risk HPV test: comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test

Katja Seme

Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2009

View PDFchevron_right

Clinical Impact of the Analytical Specificity of the Hybrid Capture 2 Test: Data from the New Technologies for Cervical Cancer (NTCC) Study

Salvatore Girlando

Journal of Clinical Microbiology, 2013

View PDFchevron_right

Analytical Comparison of the cobas HPV Test with Hybrid Capture 2 for the Detection of High-Risk HPV Genotypes

Hacène Khiri

The Journal of Molecular Diagnostics, 2012

View PDFchevron_right

Detection of human papillomavirus DNA by the hybrid capture assay

Maria Odete Carvalho

Brazilian Journal of Infectious Diseases, 2003

View PDFchevron_right

Detection of high‐risk HPV types by the hybrid capture 2 test

George Terry

Journal of Medical Virology, 2001

View PDFchevron_right

Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections

Cristina Baleriola, William Rawlinson

Journal of Clinical Virology, 2008

View PDFchevron_right

Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening

Katja Seme

Journal of Clinical Microbiology, 2011

View PDFchevron_right

Testing and Genotyping of High-Risk Human Papillomavirus by the cobas HPV Test and the Hybrid Capture 2 High-Risk HPV DNA Test Using Cervical and Vaginal Samples

Christian Law

Journal of Clinical Microbiology, 2014

View PDFchevron_right

Hybrid Capture II Testing for High-Risk Human Papillomavirus DNA in the Follow-up of Women Treated for High-Grade Cervical Intraepithelial Neoplasia

Jennifer Danielewski

Journal of Lower Genital Tract Disease, 2013

View PDFchevron_right

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions

Silvestro Carinelli

Journal of Clinical Microbiology, 2015

View PDFchevron_right

Comparison of AMPLICOR® and Hybrid Capture II® assays for high risk HPV detection in normal and abnormal liquid-based cytology: Use of INNO-LiPA Genotyping assay to screen the discordant results

Didier Riethmuller

Journal of Clinical Virology, 2008

View PDFchevron_right

Comparison of the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay for detection of high-risk human papillomavirus in women with abnormal PAP smear

Giuseppe Ciravolo, Federica Salinaro

Journal of Virological Methods, 2008

View PDFchevron_right

Multifaceted Usage of HPV Related Tests and Products in the Management of Cervical Cancer - a Review

Sivalingam Nalliah

Asian Pacific journal of cancer prevention : APJCP, 2015

View PDFchevron_right

Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer

Philip Castle

2003

View PDFchevron_right

Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible

Philip Castle

2002

View PDFchevron_right

Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance with cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of High-Grade Lesions of the Uterine Cervix

Pierre Drouin

Journal of Clinical Microbiology, 2012

View PDFchevron_right

HPV Genotype Detection Using Hybrid Capture Sample Preparation Combined with Whole Genome Amplification and Multiplex Detection with Luminex XMAP

Ha Thai

Journal of Molecular Diagnostics, 2010

View PDFchevron_right

Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic

Aparecido Da Cruz

Journal of Virological Methods, 2014

View PDFchevron_right

Statement on Human Papillomavirus DNA Test Utilization

Diane Davey

Archives of Pathology & Laboratory Medicine, 2009

View PDFchevron_right

Human Papillomavirus Infection and Cervical Carcinoma

Jong-sup Park, Ervin Adam, Hai-rim Shin

Clinical Obstetrics and Gynecology, 2000

View PDFchevron_right